Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. As with many other fields, healthcare saw the Covid-19 pandemic amplify longstanding ...

In this article, we will be taking a look at the 30 largest pharmaceutical companies in the world. To skip our detailed analysis, you can go directly to see the 10 Largest Pharmaceutical Companies in ...

The biopharmaceutical industry is facing unprecedented challenges to its fundamental business model and currently cannot sustain sufficient innovation to replace its products and revenues lost due to ...

New York, May 06, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharmaceutical Contract Manufacturing Global Market – Forecast To ...

In the dynamic landscape of global pharmaceuticals, China has solidified its position as a leading exporter of prescription drugs, with total exports reaching approximately $12.2 billion in recent ...

Collegium Pharmaceutical股票达到了一个重要里程碑，创下47.55美元的历史新高。根据InvestingPro数据，这一峰值凸显了该公司过去一年的强劲表现，期间其股价大幅上涨了56.89%。市值为15亿美元的该股票，今年至今的回报率更是高达65.27%。这家制药公司获得的投资者信心稳步增长，可能是受到其战略举措和产品管线中的有前景发展的推动。凭借87.77%的卓越毛利率以及来 ...

Although pharmaceuticals can improve health and quality of life, their mass production and use have led to pharmaceutical pollutants in the soil and water. These environmentally persistent pollutants ...

In retrospect, testimony before a US congressional committee and two departments of the European Commission late last year were 11th-hour warnings of a pending upheaval for the world’s drug supply.

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. When it comes to customer experience (CX), Walt Disney’s timeless advice has never been more ...

This success story extends beyond the pandemic. The industry has contributed to longer life spans, better disease treatments, and affordable medications. Even before the pandemic, India was the ...

The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry and outside experts are raising red flags over worsening shortages and an ...